Abeona Therapeutics falls after quarterly loss, revenue miss - ABEO News | RalliesAbeona Therapeutics falls after quarterly loss, revenue miss
A
ABEO• Shares fall after Q2 loss and revenue miss
- Shares of drugmaker Abeona Therapeutics
ABEO.O fall 17.4% to $6.16 in premarket trading.
- The company posts a Q2 loss of 35 cents per share, compared with a profit of $1.71 per share a year earlier.
- It posts Q2 revenue of $11.4 million, below analysts' average estimate of $12.2 million, according to LSEG data.
- As of last close,
ABEO was up 41.6% year to date.
HTCR
•
